Safety of lansoprazole
Colin-Jones, D.G.
British Journal of Clinical Practice. Supplement 75: 58-61; discussion 62-6
1994
ISSN/ISBN: 0262-8767 PMID: 8060803 Document Number: 424341
Document emailed within 1 workday
Related Documents
Schönhöfer, P.S. 1994: Safety of omeprazole and lansoprazole Lancet 343(8909): 1369-1370Lockhart, S.P. 1994: Clinical review of lansoprazole British Journal of Clinical Practice. Suppl 75: 48-55; Discussion: 56-57
Ghilain, J.M.; Schapira, M.; Maisin, J.M.; De Maeght, S.; Piron, A.; Gerard, R.; Henrion, J. 2000: Lymphocytic colitis associated with lansoprazole treatment Gastroenterologie Clinique et Biologique 24(10): 960-962
Mounsey, A.L. 2002: Lansoprazole ineffective for functional dyspepsia Journal of Family Practice 51(12): 1015
Scheen, A.J. 1995: Drug of the month. Lansoprazole (DakaR) Revue Medicale de Liege 50(3): 133-134
Lamouliatte, H. 1993: Effect of lansoprazole on Helicobacter pylori Clinical Therapeutics 15 Suppl B: 32-36
Vcev, A.; Stimac, D.; Vceva, A.; Rubinić, M.; Ivandić, A.; Ivanis, N.; Horvat, D.; Volarić, M.; Karner, I. 1997: Lansoprazole versus omeprazole in the treatment of reflux esophagitis Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 51(3): 171-174
Ko, J.W.; Sukhova, N.; Thacker, D.; Chen, P.; Flockhart, D.A. 1997: Evaluation of omeprazole and lansoprazole as inhibitors of cytochrome P450 isoforms Drug Metabolism and Disposition: the Biological Fate of Chemicals 25(7): 853-862
He, L.-h.; Yin, Y.; You, Y.-h.; Yan, X.-m.; Zhang, J.-z. 2003: In-vitro activity of rabeprazole, lansoprazole, and esomeprazole against Helicobacter pylori Zhonghua Liu Xing Bing Xue Za Zhi 24(6): 447-448
Dobrilla, G.; Capurso, L. 2000: Lansoprazole: an analysis of the clinical trials in the 3 years of 1997-1999 Recenti Progressi in Medicina 91(4): 191-210
Higuchi, K.; Tanabe, S.; Koizumi, W.; Nakayama, N.; Sasaki, T.; Nagaba, S.; Saigenji, K.; Katada, N. 2004: An extensive metabolizer with recurrent ulcer responding to high dose of lansoprazole Hepato-Gastroenterology 51(57): 774-776
Tamura, K.; Murai, M.; Tanaka, M.; Kawano, S. 1993: Activity of Lansoprazole (new proton pump inhibitor) against Helicobacter pylori and its therapeutic efficacy Nihon Rinsho. Japanese Journal of Clinical Medicine 51(12): 3261-3266
Nagaya, H.; Satoh, H. 1992: Possible mechanisms for (H+ + K+)-ATPase inhibition by proton pump inhibitors, omeprazole, lansoprazole and SCH 28080 Nihon Rinsho. Japanese Journal of Clinical Medicine 50(1): 26-32
De Boeck, E.; Mortier, A.V.; Jacxsens, L.; Dequidt, L.; Vlerick, P. 2017: Towards an extended food safety culture model: Studying the moderating role of burnout and jobstress, the mediating role of food safety knowledge and motivation in the relation between food safety climate and food safety behavior Trends in Food Science and Technology 62: 202-214
Chey, W.D.; Fisher, L.; Elta, G.H.; Barnett, J.L.; Nostrant, T.; DelValle, J.; Hasler, W.L.; Scheiman, J.M. 1997: Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial American Journal of Gastroenterology 92(9): 1483-1486
Kullavanijaya, P.; Gonlachanvit, S.; Mahachai, V.; Kladchareon, N. 2000: Eradication of Helicobacter pylori with lansoprazole based triple therapy in peptic ulcer disease Journal of the Medical Association of Thailand 83(3): 230-235
Petite, J.P.; Slama, J.L.; Licht, H.; Lemerez, M.; Coste, T.; Andrieu, J.; Grimaud, J.C.; Julien, H.; Dupuis, J.; Sallerin, V. 1993: Comparison of lansoprazole (30 mg) and omeprazole (20 mg) in the treatment of duodenal ulcer. a multicenter double-blind comparative trial Gastroenterologie Clinique et Biologique 17(5): 334-340
Gupta, V.K.; Dhar, A.; Srinivasan, S.; Rattan, A.; Sharma, M.P. 1997: Eradication of H. pylori in a developing country: comparison of lansoprazole versus omeprazole with norfloxacin, in a dual-therapy study American Journal of Gastroenterology 92(7): 1140-1142
Castro Fernández, M.; García Díaz, E.; Larraona, J.L.; Rodríguez Hornillo, M.C.; Lamas Rojas, E.; Núñez Hospital, D.; Pallarés Querol, M. 2006: Efficacy of low-dose lansoprazole in the treatment of non-erosive gastrooesophageal reflux disease. Influence of infection by Helicobacter pylori Revista espanola de enfermedades digestivas: organo oficial de la Sociedad Espanola de Patologia Digestiva 98(3): 170-179
Mehdi, A.; Ajmi, S. 1997: Effect of the observance of diurnal fast of Ramadan on duodenal ulcer healing with lansoprazole. Results of a prospective controlled study Gastroenterologie Clinique et Biologique 21(11): 820-822